GCTK
GlucoTrack, Inc. Common Stock
stockNASDAQ
integrity applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. since its founding in 2001, integrity applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. integrity applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. after proof of concept in 2002, integrity applications developed the first working prototype, glucotrack in august 2003. glucotrack® model df-f received ce mark approval in june 2013 and kfda in march 2016. glucotrack is currently being marketed in the european union and in south korea. the company went public in november 2011 and is
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.21 | 2026-10-02 | -14.26% | -3.955 |
| 1M | 3.23 | 2026-09-10 | -67.88% | -4.220 |
| 3M | 6.26 | 2026-07-10 | -83.43% | 9.507 |
| 6M | 9.97 | 2026-04-10 | -89.59% | 5.085 |
| 1Y | 118.65 | 2025-10-10 | -99.13% | 3.261 |
| 2Y | 40,086.00 | 2024-10-10 | -100.00% | — |
| 5Y | 297,000.00 | 2022-03-14 | -100.00% | 1.317 |
GlucoTrack, Inc. Common Stock (NASDAQ:GCTK) stock price today is $1.04, and today's volume is 236,589. GCTK is down 6.532% today. The 30 day average volume is 2.91M. GCTK market cap is $1.06M with 1.02M shares outstanding.